Optima Health — Optima Announces Brand Transition of PAM Group

(AIM:OPT) Optima Health plc announced the transition of the PAM brand, with all PAM Group brands migrating to the Optima Health name. This transition follows Optima’s acquisition of PAM Group in March 2026 and marks a significant milestone in the integration of the two businesses. Since the transaction closed, Optima has focused on integrating core teams, aligning operating structures, and unifying company culture across both organisations. The brand consolidation signals the completion of the first phase of integration and supports the company's strategy to build a stronger, best-in-class service delivery model. Jonathan Thomas, Chief Executive Officer of Optima Health, stated that bringing teams together under a common brand provides greater clarity for clients and staff, and reflects the combined strength of the two organisations. He thanked the teams for their input and dedication throughout the integration process. Optima Health is described as the UK's leading provider of technology-enabled corporate health and wellbeing solutions. The company has a team of more than 1,600, including 800 clinicians. Optima Health supports millions of employees and operates from a network of more than 50 clinics nationwide. In addition to its core UK market, Optima Health also operates in Ireland under Optima Health Ireland, providing occupational health services to clients nationwide. Andy Bones is named as CFO of Optima Health. Panmure Liberum Limited and Cavendish Capital Markets are listed as Nominated Adviser and Co-Brokers, with named representatives. ICR Healthcare is listed as UK Financial PR Adviser, with named representatives.

Full Year Trading Update

(AIM:OPT) Optima Health plc announced an unaudited trading update for the year ended 31 March 2026, reporting revenue of approximately £121 million, representing 15% growth year-on-year (FY25: £105 million) and in line with market expectations. The company recognised other income of £4.7 million relating to a previously disclosed procurement matter. Optima Health completed a transformational £100 million acquisition of PAM Healthcare Limited on 26 March 2026, with integration activity already delivering annualised synergies of £1.3 million as of 1 June 2026. The Group's net debt (excluding leases) as at 31 March 2026 was £94.4 million, comprising a cash balance of £21.6 million and £116 million of debt, with net debt reduced at the end of May following repayment of a £30 million shareholder bridging loan. New business annualised wins for FY26 were £10.8 million (FY25: £27.2 million) for Optima only, and the company maintains a robust balance sheet. The company projects FY26 adjusted EBITDA to be approximately 10% ahead of previous market expectations and targets medium-term annual revenues of £200 million and £40 million of adjusted EBITDA. Optima expects to report its Full Year Results for the year ended 31 March 2026 in August 2026.

Opthea